Edward L. Hannan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Edward L. Hannan has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
Ferdinand J. Venditti
Unaffiliated
17 shared publicationsAlice K. Jacobs
Boston Medical Center, Boston, Massachusetts
16 shared publicationsGary Walford
Johns Hopkins Medical Center, Baltimore, Maryland, USA
16 shared publicationsSpencer B. King
Emory Health System, Atlanta, Georgia
16 shared publicationsPeter B. Berger
Unaffiliated
15 shared publicationsKimberly Cozzens
University at Albany, State University of New York, Albany, New York
13 shared publications
Latest Publications
- 8 September 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 206, 23-30
New York Risk Model and Simplified Risk Score for In-Hospital/30-Day Mortality for Percutaneous Coronary Intervention
- 8 September 2023
- Published by Elsevier in The American Journal of Cardiology
- Vol. 206, 23-30
New York Risk Model and Simplified Risk Score for In-Hospital/30-Day Mortality for Percutaneous Coronary Intervention
- 24 July 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (14) , 1733-1742
Ad Hoc Percutaneous Coronary Intervention in Stable Patients With Multivessel or Unprotected Left Main Disease
- 24 July 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (14) , 1733-1742
Ad Hoc Percutaneous Coronary Intervention in Stable Patients With Multivessel or Unprotected Left Main Disease
- 10 July 2023
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 39 (9) , 1228
Re-examination of Neighbourhood Atlas Area Deprivation Index for Risk-Adjusting PCI Outcomes
- 10 July 2023
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 39 (9) , 1228
Re-examination of Neighbourhood Atlas Area Deprivation Index for Risk-Adjusting PCI Outcomes
- 4 July 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 116 (5) , 1117-1118
Re-examination of Area Deprivation Index for Risk-Adjusting CABG Surgery Outcomes
- 4 July 2023
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 116 (5) , 1117-1118
Re-examination of Area Deprivation Index for Risk-Adjusting CABG Surgery Outcomes
- Top Cited Papers
- 1 May 2023
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 42 (5) , 702-709
The Neighborhood Atlas Area Deprivation Index For Measuring Socioeconomic Status: An Overemphasis On Home Value
The Area Deprivation Index (ADI), popularized by the Neighborhood Atlas, is a multifaceted proxy measure for assessing socioeconomic disadvantage that captures social risk factors that are not available in typical clinical registries and that are related to adverse health outcomes. In applying the ADI to New York State, we found that the downstate regions (New York City and its suburbs) were as deprived as or more deprived than the other regions for thirteen of the seventeen ADI variables (all but the ones measured in dollars), but the Neighborhood Atlas-computed overall ADI deprivation was much less in the downstate areas. Numerous census block groups with high home values (indicating low deprivation) accompanied by high deprivation in the other ADI variables had overall ADI scores as computed by the Neighborhood Atlas in the same or contiguous deciles as the home values. We concluded that Neighborhood Atlas-computed ADI scores for New York block groups are mainly representative of median home value. This can be especially problematic when considering quality assessment, funding, and resource allocation in regions with large variations in cost of living, and it may result in underresourcing for disadvantaged communities with high housing prices. We conclude that the Neighborhood Atlas ADI would be more accurate for comparing block groups if variables were standardized before computing the overall index.
- 1 May 2023
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 42 (5) , 702-709
Top Cited PapersThe Neighborhood Atlas Area Deprivation Index For Measuring Socioeconomic Status: An Overemphasis On Home Value
The Area Deprivation Index (ADI), popularized by the Neighborhood Atlas, is a multifaceted proxy measure for assessing socioeconomic disadvantage that captures social risk factors that are not available in typical clinical registries and that are related to adverse health outcomes. In applying the ADI to New York State, we found that the downstate regions (New York City and its suburbs) were as deprived as or more deprived than the other regions for thirteen of the seventeen ADI variables (all but the ones measured in dollars), but the Neighborhood Atlas-computed overall ADI deprivation was much less in the downstate areas. Numerous census block groups with high home values (indicating low deprivation) accompanied by high deprivation in the other ADI variables had overall ADI scores as computed by the Neighborhood Atlas in the same or contiguous deciles as the home values. We concluded that Neighborhood Atlas-computed ADI scores for New York block groups are mainly representative of median home value. This can be especially problematic when considering quality assessment, funding, and resource allocation in regions with large variations in cost of living, and it may result in underresourcing for disadvantaged communities with high housing prices. We conclude that the Neighborhood Atlas ADI would be more accurate for comparing block groups if variables were standardized before computing the overall index.
- 1 April 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 101 (6) , 980-994
Impact of COVID‐19 on percutaneous coronary intervention utilization and mortality in New York
Background: COVID‐19 has disrupted the care of all patients, and little is known about its impact on the utilization and short‐term mortality of percutaneous coronary intervention (PCI) patients, particularly nonemergency patients.Methods: New York State's PCI registry was used to study the utilization of PCI and the presence of COVID‐19 in four patient subgroups ranging in severity from ST‐elevation myocardial infarction (STEMI) to elective patients before (December 01, 2018–February 29, 2020) and during the COVID‐19 era (March 01, 2020–May 31, 2021), as well as to examine the impact of different COVID severity levels on the mortality of different types of PCI patients.Results: Decreases in the mean quarterly PCI volume from the prepandemic period to the first quarter of the pandemic ranged from 20% for STEMI patients to 61% for elective patients, with the other two subgroups having decreases in between these values. PCI quarterly volume rebounds from the prepandemic period to the second quarter of 2021 were in excess of 90% for all patient subgroups, and 99.7% for elective patients. Existing COVID‐19 was rare among PCI patients, ranging from 1.74% for STEMI patients to 3.66% for elective patients. PCI patients with COVID‐19 and acute respiratory distress syndrome (ARDS) who were not intubated, and PCI patients with COVID‐19 and ARDS who were either intubated or were not intubated because of Do Not Resuscitate//Do Not Intubate status had higher risk‐adjusted mortality ([adjusted ORs = 10.81 [4.39, 26.63] and 24.53 [12.06, 49.88], respectively]) than patients who never had COVID‐19.Conclusions: There were large decreases in the utilization of PCI during COVID‐19, with the percentage of decrease being highly sensitive to patient acuity. By the second quarter of 2021, prepandemic volumes were nearly restored for all patient subgroups. Very few PCI patients had current COVID‐19 throughout the pandemic period, but the number of PCI patients with a COVID‐19 history increased steadily during the pandemic. PCI patients with COVID‐19 accompanied by ARDS were at much higher risk of short‐term mortality than patients who never had COVID‐19. COVID‐19 without ARDS and history of COVID‐19 were not associated with higher mortality for PCI patients as of the second quarter of 2021.
- 1 April 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 101 (6) , 980-994
Impact of COVID‐19 on percutaneous coronary intervention utilization and mortality in New York
Background: COVID‐19 has disrupted the care of all patients, and little is known about its impact on the utilization and short‐term mortality of percutaneous coronary intervention (PCI) patients, particularly nonemergency patients.Methods: New York State's PCI registry was used to study the utilization of PCI and the presence of COVID‐19 in four patient subgroups ranging in severity from ST‐elevation myocardial infarction (STEMI) to elective patients before (December 01, 2018–February 29, 2020) and during the COVID‐19 era (March 01, 2020–May 31, 2021), as well as to examine the impact of different COVID severity levels on the mortality of different types of PCI patients.Results: Decreases in the mean quarterly PCI volume from the prepandemic period to the first quarter of the pandemic ranged from 20% for STEMI patients to 61% for elective patients, with the other two subgroups having decreases in between these values. PCI quarterly volume rebounds from the prepandemic period to the second quarter of 2021 were in excess of 90% for all patient subgroups, and 99.7% for elective patients. Existing COVID‐19 was rare among PCI patients, ranging from 1.74% for STEMI patients to 3.66% for elective patients. PCI patients with COVID‐19 and acute respiratory distress syndrome (ARDS) who were not intubated, and PCI patients with COVID‐19 and ARDS who were either intubated or were not intubated because of Do Not Resuscitate//Do Not Intubate status had higher risk‐adjusted mortality ([adjusted ORs = 10.81 [4.39, 26.63] and 24.53 [12.06, 49.88], respectively]) than patients who never had COVID‐19.Conclusions: There were large decreases in the utilization of PCI during COVID‐19, with the percentage of decrease being highly sensitive to patient acuity. By the second quarter of 2021, prepandemic volumes were nearly restored for all patient subgroups. Very few PCI patients had current COVID‐19 throughout the pandemic period, but the number of PCI patients with a COVID‐19 history increased steadily during the pandemic. PCI patients with COVID‐19 accompanied by ARDS were at much higher risk of short‐term mortality than patients who never had COVID‐19. COVID‐19 without ARDS and history of COVID‐19 were not associated with higher mortality for PCI patients as of the second quarter of 2021.
- Open Access
- 3 January 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (2)
Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality
- 3 January 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (2)
Open AccessShort-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality
- 9 December 2022
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (1) , E7-+
Utilization Trends and Short-Term Outcomes for Transcatheter and Surgical Aortic Valve Replacement Surgery in New York
The authors describe the utilization trends, compare baseline characteristics, and evaluate short-term outcomes of TAVR vs SAVR from 2011-2018 in New York.
- 9 December 2022
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (1) , E7-+
Utilization Trends and Short-Term Outcomes for Transcatheter and Surgical Aortic Valve Replacement Surgery in New York
The authors describe the utilization trends, compare baseline characteristics, and evaluate short-term outcomes of TAVR vs SAVR from 2011-2018 in New York.